Literature DB >> 6282215

Antimicrobial susceptibility of Bordetella pertussis strains isolated from 1960 to 1981.

R M Bannatyne, R Cheung.   

Abstract

The susceptibilities to erythromycin, rifampin, polymyxin B, ampicillin, tetracycline, gentamicin, fusidic acid, trimethoprim, and spectinomycin of 100 strains of Bordetella pertussis isolated between 1960 and 1981 were compared. No change in susceptibility to any of these drugs was noted.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6282215      PMCID： PMC181963          DOI： 10.1128/AAC.21.4.666

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Trimethoprim-sulphamethoxazole in pertussis: comparison with tetracycline.

Authors:  K J Adcock; S Reddy; O A Okubadejo; D Montefiore
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

2.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

3.  Susceptibility of Bordetella pertussis to nine antimicrobial agents.

Authors:  J W Bass; F W Crast; J B Kotheimer; I A Mitchell
Journal:  Am J Dis Child       Date:  1969-03

4.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

5.  Antibiotic susceptibility testing of Bordetella pertussis.

Authors:  L H Field; C D Parker
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493
  5 in total
  7 in total

1.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Authors:  J E Hoppe; A Bryskier
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

4.  Influence of culture medium and inoculum size on susceptibility of Bordetella pertussis to antibacterial agents in vitro.

Authors:  G Zackrisson; J E Brorson; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

5.  Antibiotic resistance of degraded strains of Bordetella pertussis.

Authors:  R M Bannatyne; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.

Authors:  B C Hill; C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  Development and Standardization of a High-Throughput Bordetella pertussis Growth-Inhibition Assay.

Authors:  Anaïs Thiriard; Dominique Raze; Camille Locht
Journal:  Front Microbiol       Date:  2020-04-23       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.